恶性黑色素瘤的放射治疗
2022/10/26 17:53:08 中国医药教育协会肿瘤放疗专委会

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

    

     附 ANZMTG 01.02/TROG 02.01英文摘要

     Adjuvant lymph-node field radiotherapy versus observation only in patients with melanoma at high risk of further lymph-node fi eld relapse after lymphadenectomy (ANZMTG 01.02/TROG 02.01): 6-year follow-up of a phase 3, randomised controlled trial

     Background：Adjuvant radiotherapy is recommended for patients with melanoma after lymphadenectomy. We previously showed this treatment reduced risk of repeat lymph-node fi eld cancer in patients with a high risk of recurrence but had no eff ect on overall survival. Here, we aim to update the relapse and survival data from that trial and assess quality of life and toxic eff ects.

    

    

    

    

     扫码关注我们

     “专委会”官方微信公众号

     微信号 : CMERO_mishuchu

     本文转载自公众号：Rad Onco，文中内容不作商业用途，仅作交流学习，版权归原作者。更多精彩内容请关注专委会公众号，您的支持就是我们前进的最大动力。

    源网页  http://weixin.100md.com
返回 中国医药教育协会肿瘤放疗专委会 返回首页 返回百拇医药